Approval · Notice of Compliance 24485 · 2020
ADVANTAGE MULTI 100: Notice of Compliance 24485
Issued October 23, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24485
- Date
- October 23, 2020
- Company
- Elanco Canada LimitedGuelph, Ontario, Canada
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in product ownership
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ADVANTAGE MULTI 100 | 02263564 | Marketed |
Medicinal ingredients
- MOXIDECTIN 100 MG per 4ML
- IMIDACLOPRID 400 MG per 4ML